We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

149 hedge funds and large institutions have $1.74B invested in Axonics, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 45 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 45

1% more capital invested

Capital invested by funds: $1.72B → $1.74B (+$13.7M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

4% less first-time investments, than exits

New positions opened: 26 | Existing positions closed: 27

1% less funds holding

Funds holding: 151149 (-2)

26% less call options, than puts

Call options by funds: $11.8M | Put options by funds: $16M

Holders
149
Holders Change
-2
Holders Change %
-1.32%
% of All Funds
2.64%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
26
Increased
56
Reduced
45
Closed
27
Calls
$11.8M
Puts
$16M
Net Calls
-$4.23M
Net Calls Change
-$44.9M
Name Holding Trade Value Shares
Change
Change in
Stake
PI
76
PEAK6 Investments
Illinois
$1.29M +$223K +4,752 +23%
NAM
77
Nexpoint Asset Management
Texas
$998K
UBS AM
78
UBS AM
Illinois
$994K -$225K -4,800 -19%
Ameriprise
79
Ameriprise
Minnesota
$986K +$87.8K +1,871 +10%
DCM
80
Dupont Capital Management
Delaware
$923K +$868K +18,484 New
Manulife (Manufacturers Life Insurance)
81
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$911K +$22.9K +488 +3%
E
82
Ergoteles
New York
$904K +$850K +18,100 New
GTCM
83
Gyon Technologies Capital Management
New Jersey
$893K +$840K +17,894 New
PPA
84
Parametric Portfolio Associates
Washington
$838K -$1.12M -23,836 -59%
QT
85
Quantbot Technologies
New York
$819K +$771K +16,411 New
Principal Financial Group
86
Principal Financial Group
Iowa
$791K +$192K +4,099 +35%
WG
87
Winton Group
United Kingdom
$728K -$1.76M -37,380 -72%
Squarepoint
88
Squarepoint
New York
$724K +$681K +14,512 New
BFM
89
Boothbay Fund Management
New York
$717K +$674K +14,353 New
JP Morgan Chase
90
JP Morgan Chase
New York
$698K +$83.9K +1,788 +15%
MIM
91
MetLife Investment Management
New Jersey
$688K
CF
92
CNA Financial
Illinois
$651K +$51.5K +1,097 +9%
ACM
93
AlphaCrest Capital Management
New York
$634K +$127K +2,700 +27%
Royal Bank of Canada
94
Royal Bank of Canada
Ontario, Canada
$625K +$116K +2,471 +25%
Simplex Trading
95
Simplex Trading
Illinois
$581K +$51.1K +1,089 +10%
MWNA
96
Marshall Wace North America
New York
$573K +$539K +11,476 New
AC
97
Avestar Capital
New York
$560K +$219K +4,654 +71%
Barclays
98
Barclays
United Kingdom
$528K -$164K -3,488 -25%
QSS
99
Quantitative Systematic Strategies
Florida
$510K -$101K -2,158 -17%
TD Asset Management
100
TD Asset Management
Ontario, Canada
$507K +$37.6K +800 +9%

AXNX Hedge Fund Activity: Q4 2020 in Review

149 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2020, worth a combined $1.74B — up 0.8% from $1.72B a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of AXNX and 26 opened new positions — a net loss of 1 holder — while 45 trimmed existing stakes and 56 added.

The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $44M. The largest seller was Redmile Group, exiting entirely with an estimated $37.8M sold.

  • 149 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2020, down from 151 in Q3 2020.
  • Funds reported $1.74B of Axonics, Inc. Common Stock stock for Q4 2020, up 0.8% quarter-over-quarter.
  • 26 funds opened new Axonics, Inc. Common Stock positions in Q4 2020 and 27 closed out, a net change of -1 holder.
  • The largest Axonics, Inc. Common Stock buyer in Q4 2020 was Loomis, Sayles & Company, an estimated $44M added.
  • The largest Axonics, Inc. Common Stock seller in Q4 2020 was Redmile Group, an estimated $37.8M sold.

Based on aggregated 13F filings for Q4 2020.